RCKT logo

Rocket Pharmaceuticals Inc

RCKT

$30.53

+ $0.38 (1.30%) This month

Closed: 29 Feb 2024 21:00 US/Eastern

Key details

CEO

David Southwell

Employees

205

Headquarters

New York, US

Sector

Manufacturing

Industry

Pharmaceutical Preparation Manufacturing

About Rocket Pharmaceuticals Inc

rocket pharmaceuticals, ltd is a biotechnology company focused on seeking cures through molecular and gene therapy. we are developing first-in-class treatments for patients with rare and often devastating orphan diseases using a lentiviral-based gene therapy approach. we have developed rewarding partnerships with a number of leading international research institutions as well as with centers of manufacturing and cell processing expertise, while building an internal team to drive the research, development, clinical and regulatory programs. ultimately we aim to launch and globally commercialize innovative gene therapies in disease areas with high unmet need. for more information, please visit www.rocketpharma.com.

Please treat this data as an indicator only since we can't always guarantee that it's accurate or complete. Bear in mind too that the prices you'll see are delayed by at least 15 minutes. Intraday pricing and company data provided by IEX.
Finimize
© Finimize Ltd. 2023. 10328011. 280 Bishopsgate, London, EC2M 4AG